PTC Therapeutics, Inc. (PTCT) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$63.16
Day's range
$69.17

PTC Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 02/12/2026 12.78 M $970.70 M   79.21% 15.68%
VANGUARD GROUP INC 01/29/2026 8.80 M $668.69 M   6.20% 10.80%
RTW INVESTMENTS, LP 02/17/2026 7.75 M $588.42 M   0.00% 9.51%
JANUS HENDERSON GROUP PLC 02/17/2026 4.85 M $368.59 M   28.56% 5.95%
STATE STREET CORP 02/13/2026 4.21 M $319.50 M   34.18% 5.16%
TORONTO DOMINION BANK 02/17/2026 4.14 M $314.34 M   27.47% 5.08%
WELLINGTON MANAGEMENT GROUP LLP 02/17/2026 3.87 M $293.77 M   -21.37% 4.75%
ARMISTICE CAPITAL, LLC 02/17/2026 2.80 M $212.83 M   -14.51% 3.44%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 2.02 M $153.16 M   3.34% 2.47%
D. E. SHAW & CO., INC. 02/17/2026 1.74 M $132.55 M   -19.76% 2.14%
FMR LLC 02/17/2026 1.68 M $127.71 M   4.31% 2.06%
JEFFERIES FINANCIAL GROUP INC. 02/09/2026 1.66 M $125.98 M   4.66% 2.04%
TANG CAPITAL MANAGEMENT LLC 02/17/2026 1.50 M $113.94 M   0.00% 1.84%
BANK OF AMERICA CORP /DE/ 02/17/2026 1.43 M $108.74 M   -5.63% 1.76%
FRANKLIN RESOURCES INC 02/11/2026 1.29 M $97.74 M   11.21% 1.58%
CITADEL ADVISORS LLC 02/17/2026 1.15 M $87.69 M   -33.31% 1.42%
DRIEHAUS CAPITAL MANAGEMENT LLC 02/17/2026 1.14 M $86.30 M   0.39% 1.39%
POINT72 ASSET MANAGEMENT, L.P. 02/17/2026 1.13 M $85.72 M   -7.54% 1.38%
GOLDMAN SACHS GROUP INC 03/25/2026 1.02 M $77.71 M   16.74% 1.26%
HOOD RIVER CAPITAL MANAGEMENT LLC 02/17/2026 1.00 M $76.19 M   0.73% 1.23%
PICTET ASSET MANAGEMENT HOLDING SA 01/29/2026 978.96 K $74.79 M   -30.47% 1.20%
UBS GROUP AG 01/29/2026 964.66 K $73.28 M   113.32% 1.18%
MORGAN STANLEY 02/13/2026 905.19 K $68.76 M   115.82% 1.11%
PALO ALTO INVESTORS LP 02/17/2026 903.92 K $68.66 M   4.79% 1.11%
SG AMERICAS SECURITIES, LLC 01/09/2026 894.46 K $67.94 M   587.53% 1.10%
BNP PARIBAS ARBITRAGE, SNC 02/10/2026 828.66 K $62.95 M   4,013.08% 1.02%
NORTHERN TRUST CORP 02/17/2026 769.42 K $58.45 M   4.32% 0.94%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 734.93 K $55.83 M   4.58% 0.90%
NUVEEN, LLC 02/12/2026 699.19 K $53.11 M   -3.05% 0.86%
AVORO CAPITAL ADVISORS LLC 03/16/2026 685.00 K $52.03 M   100.00% 0.84%
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. 02/13/2026 647.59 K $49.19 M   -19.14% 0.79%
LORD, ABBETT & CO. LLC 02/13/2026 627.11 K $47.64 M   65.88% 0.77%
DIMENSIONAL FUND ADVISORS LP 02/12/2026 627.09 K $47.63 M   -18.89% 0.77%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 607.59 K $46.15 M   -34.48% 0.75%
WOODLINE PARTNERS LP 02/17/2026 571.55 K $43.42 M   441.22% 0.70%
BANK OF NEW YORK MELLON CORP 02/10/2026 514.68 K $39.10 M   88.48% 0.63%
BOSTON PARTNERS 02/13/2026 487.98 K $37.07 M   34.93% 0.60%
PRINCIPAL FINANCIAL GROUP INC 02/02/2026 478.90 K $36.38 M   607.62% 0.59%
PRICE T ROWE ASSOCIATES INC /MD/ 02/17/2026 460.11 K $34.95 M   0.39% 0.56%
INVESCO LTD. 02/19/2026 434.29 K $32.99 M   38.72% 0.53%
BIOIMPACT CAPITAL LLC 02/17/2026 430.01 K $32.66 M   -1.93% 0.53%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 02/13/2026 426.51 K $32.40 M   0.35% 0.52%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 02/13/2026 406.41 K $30.87 M   25.61% 0.50%
ROCKEFELLER CAPITAL MANAGEMENT L.P. 03/17/2026 405.54 K $30.80 M   -14.40% 0.50%
LEGAL & GENERAL GROUP PLC 02/09/2026 366.27 K $27.82 M   51.76% 0.45%
JUPITER ASSET MANAGEMENT LTD 02/10/2026 361.16 K $27.43 M   100.00% 0.44%
PANAGORA ASSET MANAGEMENT INC 02/13/2026 359.84 K $27.33 M   3.29% 0.44%
JPMORGAN CHASE & CO 02/11/2026 356.04 K $27.04 M   -27.48% 0.44%
AQR CAPITAL MANAGEMENT LLC 02/17/2026 341.93 K $25.97 M   3.22% 0.42%
VOYA INVESTMENT MANAGEMENT LLC 02/12/2026 339.15 K $25.76 M   19.04% 0.42%

PTC Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 473 institutional investors and hedge funds held shares of PTC Therapeutics Inc. The most heavily invested institutionals were:

UBS Group AG: 1.36 M

Pictet Asset Management Holding SA: 1.18 M

SG Americas Securities, LLC: 879,701

Nuveen, LLC: 667,019

Bank of New York Mellon Corp: 522,763

PRINCIPAL FINANCIAL GROUP INC: 515,001

113.75% of PTC Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 112.75 M shares in the last 24 months. This purchase volume represents approximately $7.71 B in transactions.